Efficacy and Safety of Nitazoxanide in Preventing Recurrence of Hepatic Encephalopathy

Recruiting now · Phase 3

Conditions studied: Hepatic Encephalopathy

In brief

Efficacy and Safety of Nitazoxanide in preventing recurrence of Hepatic Encephalopathy.

Key facts

Study ID

NCT04161053

Run by

Tanta University

People needed

60

Starts

2018-11-01

Expected to finish

2028-12-01

Last updated by the study team

2019-11-13

Who can join

Age: 20 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Cirrhotic patient with at least one previous episode of hepatic encephalopathy.
• Adult Patients aging from 20 to 65 years old

You may not qualify if…

• Active GIT bleeding.
• Major psychiatric illness (psychosis \& epilepsy).
• Renal insufficiency (S.Cr 2mg/dl).

Where it is running

• Sherief Abd-Elsalam — Tanta, Egypt (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.